Verition Fund Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-73,454
| Closed | -$1.32M | – | 3098 |
|
|
2025
Q1 | $1.32M | Sell |
73,454
-2,854
| -4% | -$51.1K | 0.01% | 1463 |
|
|
2024
Q4 | $1.33M | Buy |
76,308
+15,437
| +25% | +$269K | 0.01% | 1383 |
|
|
2024
Q3 | $852K | Buy |
60,871
+32,583
| +115% | +$456K | ﹤0.01% | 1408 |
|
|
2024
Q2 | $233K | Buy |
+28,288
| New | +$233K | ﹤0.01% | 1869 |
|
|
2023
Q3 | – | Sell |
-10,050
| Closed | -$154K | – | 2274 |
|
|
2023
Q2 | $154K | Buy |
+10,050
| New | +$154K | ﹤0.01% | 1637 |
|